The PI3K/AKT/mTOR pathway is generally activated in head and neck squamous cell carcinoma (HNSCC) but pathway inhibition has variable efficacy. inhibitors using a diverse selection of goals and by determining mechanisms of level of resistance and potential mixture therapies. We utilized reverse-phase proteins arrays (RPPA) to concurrently evaluate appearance of 195 protein; single-nucleotide polymorphism array… Continue reading The PI3K/AKT/mTOR pathway is generally activated in head and neck squamous